Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017)

被引:1
作者
Busard, Celine [1 ]
Menting, Stef [1 ]
van Bezooijen, S. J. [2 ]
van den Reek, Juul [3 ]
Hutten, Barbara [4 ]
Prens, Errol [2 ]
de Jong, Elke [3 ]
van Doorn, Martijn [2 ]
Spuls, Phyllis [1 ]
机构
[1] Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands
[2] Erasmus Univ, Dept Dermatol, Med Ctr, Rotterdam, Netherlands
[3] Radboud Univ Nijmegen, Dept Dermatol, Med Ctr, Nijmegen, Netherlands
[4] Acad Med Ctr, Dept Clin Epidemiol Biostatist & Bioinform, Amsterdam, Netherlands
关键词
D O I
10.1186/s13063-017-1848-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页数:1
相关论文
共 2 条
[1]  
[Anonymous], 2017, TRIALS, V18, P52, DOI [10.1186/s13063-017-1777-y, DOI 10.1186/S13063-017-1777-Y]
[2]   Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial [J].
Busard, Celine ;
Menting, Stef ;
van Bezooijen, Sun-Jine ;
van den Reek, Juul ;
Hutten, Barbara ;
Prens, Errol ;
de Jong, Elke ;
van Doorn, Martijn ;
Spuls, Phyllis .
TRIALS, 2017, 18